Literature DB >> 18726097

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido.

Yutaka Tsutsumi, Akio Shigematsu, Satoshi Hashino, Junji Tanaka, Kouji Chiba, Nobuo Masauzi, Hajime Kobayashi, Mitsutoshi Kurosawa, Hiroshi Iwasaki, Masanobu Morioka, Masahiro Asaka, Masahiro Imamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18726097     DOI： 10.1007/s00277-008-0585-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  Management of hepatitis B reactivation in patients receiving cancer chemotherapy.

Authors:  Yi-Wen Huang; Raymond T Chung
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

2.  Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.

Authors:  Panayiotis D Ziakas; Petros Karsaliakos; Eleftherios Mylonakis
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

Review 3.  Hepatitis B virus reactivation with a rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Shinichi Ito; Hiroyuki Ohigashi; Souichi Shiratori; Hirohito Naruse; Takanori Teshima
Journal:  World J Hepatol       Date:  2015-09-28

4.  An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.

Authors:  Xiang-Yuan Wu; Xing Li; Zhan-Hong Chen; Jing-Yun Wen; Qu Lin; Yan-Fang Xing; Min Dong; Li Wei; Tian-Tian Wang; Jie Chen; Ze-Xiao Lin; Xiang-bo Wan; Dan-Yun Ruan; Xiao-Kun Ma
Journal:  Tumour Biol       Date:  2012-12-27

Review 5.  Management of rheumatic disease with comorbid HBV or HCV infection.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

Review 6.  Hepatitis B virus reactivation with rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Joji Shimono; Hiroyuki Ohhigashi; Takanori Teshima
Journal:  World J Hepatol       Date:  2013-11-27

7.  Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.

Authors:  Fan Yang; Huan-Ling Zhu; Chuan He; Jian-Jun Li; Bing Xiang; Xu Cui; Jie Huang; Jie Ji; Hong-Bing Ma; Ting Liu
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-30       Impact factor: 0.900

8.  Rituximab administration and reactivation of HBV.

Authors:  Yutaka Tsutsumi; Reiki Ogasawara; Yusuke Kamihara; Shinichi Ito; Yoshiya Yamamoto; Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Hepat Res Treat       Date:  2010-12-01

Review 9.  Treatment of rheumatic diseases and hepatitis B virus coinfection.

Authors:  Anna Felis-Giemza; Marzena Olesińska; Katarzyna Świerkocka; Ewa Więsik-Szewczyk; Ewa Haładyj
Journal:  Rheumatol Int       Date:  2014-12-31       Impact factor: 2.631
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.